Viewing Study NCT02406508


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-02-18 @ 7:51 AM
Study NCT ID: NCT02406508
Status: WITHDRAWN
Last Update Posted: 2017-12-18
First Post: 2015-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Sponsor: Delcath Systems Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module